Aro Biotherapeutics

CIC Philadelphia

3675 Market Street, Suite 200

Philadelphia, PA 19104

Email: info@arobiotx.com 

Aro LinkedIn

© 2018 Aro Biotherapeutics Company. All Rights Reserved.

ARO BIOTHERAPEUTICS USE OF LINKEDIN AND SOCIAL MEDIA

Aro Biotherapeutics (“Aro”) is a user of LinkedIn and other social media properties and maintains a corporate LinkedIn account.

Aro recognizes the importance of social media, including LinkedIn, and new communication channels that enable Aro to engage in interactive discussion. Aro is committed to abide by the legal, ethical and regulatory standards applicable to the Company. Aro aims to have responsible social interactions.

 

DISCLAIMERS

Aro may respond to questions and comments presented via LinkedIn and other social media properties, when appropriate. Aro may not be able to immediately respond to questions or comments, and responses, if any, may be limited in nature.

 

There may be questions and/or comments Aro cannot address, including, but not limited to, questions related to non-public confidential information, proprietary information, financial matters, ongoing legal matters, regulatory issues and other aspects of Aro’s business. Aro will not respond to rumors, personal attacks, foul language, disparaging comments or topics that do not relate directly to Aro.

 

Social media accounts that Aro follows or is followed by do not indicate an endorsement of the account owner or its products and services.

Aro may provide links or references to external websites, not controlled by Aro, as part of its social media content. However, Aro does not endorse or claim responsibility for the content of such other websites. Any links or references to such external websites are provided as merely a convenience to the users of the respective social media platform.

 

Aro reserves all rights relating to the Aro LinkedIn account and its other social media properties including, but not limited to, all rights to add, remove or modify any content or material posted on the account, discontinue the account, accept or reject those who may wish to follow the account and respond to, or refrain from responding to, any questions or comments addressed to the account.